SCHEMBL6589132

SCHEMBL6589132

CC1(OC(=O)/C=C/C(=O)OC2(C)c3ccccc3C(=O)N2c2ccncc2)c2ccccc2C(=O)N1c1ccncc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.53
TSHR P16473 2/20 0.41
TP53 P04637 1/20 0.41
PGR P06401 3/20 0.36
LMNA P02545 1/20 0.35
BRAF P15056 2/20 0.34
RAF1 P04049 1/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
ALDH1A1 P00352 4/20 0.33
KDM4E B2RXH2 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
HPGD P15428 2/20 0.33
CYP46A1 Q9Y6A2 1/20 0.33
KCNQ2 O43526 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
ALOX15 P16050 1/20 0.33
NPC1 O15118 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6589332 0.83 RXFP1 (0.49) RXFP1TSHRTP53PGRLMNA
Fumaric Acid SCHEMBL6588746 0.78 RXFP1 (0.60) RXFP1TSHRTP53PGRLMNA
Fumaric Acid SCHEMBL6588742 0.78 RXFP1 (0.60) RXFP1TSHRTP53PGRLMNA
SCHEMBL6589296 0.77 RXFP1 (0.66) RXFP1TSHRTP53PGRCYP11B1
SCHEMBL6587765 0.74 LMNA (0.34) RXFP1TSHRLMNAALDH1A1KDM4E
Maleic Acid SCHEMBL6589328 0.72 RXFP1 (0.56) RXFP1TSHRTP53PGRALDH1A1
Fumaric Acid SCHEMBL6589338 0.72 RXFP1 (0.56) RXFP1TSHRTP53PGRALDH1A1
SCHEMBL6586651 0.71 RXFP1 (0.61) RXFP1TSHRTP53PGRALDH1A1
SCHEMBL6587023 0.69 RXFP1 (0.59) RXFP1TSHRTP53PGRALDH1A1
SCHEMBL29155436 0.64 RXFP1 (0.55) RXFP1TSHRTP53PGRBRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0703232-B1 2,3-Dihydro-1H-isoindole derivates, a process for their preparation and their use as serotonin reuptake inhibitors AVENTIS PHARMA INC (US) 2004-06-30 EP claimed
US-5567718-A PSYCHOLOGICAL DISORDERS HOECHST MARION ROUSSEL INC. (US) 1996-10-22 US claimed
EP-0703232-A2 2,3-Dihydro-1H-isoindole derivates, a process for their preparation and their use as serotonin reuptake inhibitors HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1996-03-27 EP claimed
EP-0703232-B1 2,3-Dihydro-1H-isoindole derivates, a process for their preparation and their use as serotonin reuptake inhibitors AVENTIS PHARMA INC (US) 2004-06-30 EP disclosed
US-5874458-A PSYCHOLOGICAL DISORDERS HOECHST MARION ROUSSEL INC. (US) 1999-02-23 US disclosed
US-5874583-A TREATING DEPRESSION, OBSESSIVE COMPULSIVE DISORDER, STUTTERING, TRICHOTILLOMANIA HOECHST MARION ROUSSEL INC. (US) 1999-02-23 US disclosed
US-5869685-A SEROTONIN REUPTAKE INHIBITORS HOECHST MARION ROUSSEL INC. (US) 1999-02-09 US disclosed
US-5869502-A TREATING DEPRESSION, OBSESSIVE COMPULSIVE DISORDER, STUTTERING, TRICHOTILLOMANIA HOECHST MARION ROUSSEL INC. (US) 1999-02-09 US disclosed
US-5567718-A PSYCHOLOGICAL DISORDERS HOECHST MARION ROUSSEL INC. (US) 1996-10-22 US disclosed
EP-0703232-A2 2,3-Dihydro-1H-isoindole derivates, a process for their preparation and their use as serotonin reuptake inhibitors HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1996-03-27 EP disclosed